Psychedelics Archives - Page 2 of 10

Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — October 2025

Commentary by Gregory Ferenstein

Psychedelics Policy Newsletter: RFK Jr. gives hopeful approval timeline, Arizona advances ibogaine, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — August 2025

Commentary by Gregory Ferenstein

Arizona joins Texas in ibogaine clinical trial research push for veteran, first responder mental health

Commentary by Leonard Gilroy

Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — June 2025

Commentary by Gregory Ferenstein

Iowa House File 978 would regulate psilocybin access and benefit veterans’ mental health

Testimony by Leonard Gilroy and Geoffrey Lawrence

Ibogaine offers major promise in treating addiction, mental health

Backgrounder by Madison Carlino and Leonard Gilroy

More Psychedelics

Prev
1
2
3
4
5
6
7
...
10
Next